Tolperisone hydrochloride improves motor functions in Parkinson’s disease via MMP-9 inhibition and by downregulating p38 MAPK and ERK1/2 signaling cascade-Reference-Cited by-同舟云学术

Tolperisone hydrochloride improves motor functions in Parkinson’s disease via MMP-9 inhibition and by downregulating p38 MAPK and ERK1/2 signaling cascade

Published:2024-05 Issue: Volume:174 Page:116438
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Zaman Bushra^ORCID,Mostafa Irona,Hassan Tazree,Ahmed Shamim^ORCID,Esha Nusrat Jahan Ikbal,Chowdhury Fowzia Afsana,Bosu Tory,Chowdhury Humayra Noor,Mallick Anup,Islam MM Shanjid,Sharmin Ayesha^ORCID,Uddin Kabir M.,Hossain Md. Mainul^ORCID,Rahman Mahbubur^ORCID

Funder

Government of Bangladesh Ministry of Science and Technology

North South University

Publisher

Elsevier BV

Reference110 articles.

1. Parkinson’s disease: etiology;Kouli;Neuropathol. Pathog. Exon Publ.,2018

2. Parkinson's disease;Mhyre;Sub-Cell. Biochem. 65,2012

3. K.R. Gandhi, A. Saadabadi, Levodopa (L-Dopa), StatPearls, StatPearls Publishing Copyright © 2024, StatPearls Publishing LLC., Treasure Island (FL) ineligible companies. Disclosure: Abdolreza Saadabadi declares no relevant financial relationships with ineligible companies., 2024.

4. The risk factors for the wearing-off phenomenon in Parkinson's disease in japan: a cross-sectional, multicenter study;Ouma;Intern. Med.,2017

5. S. Zafar, S.S. Yaddanapudi, Parkinson Disease, StatPearls, StatPearls Publishing Copyright © 2024, StatPearls Publishing LLC., Treasure Island (FL) ineligible companies. Disclosure: Sridhara Yaddanapudi declares no relevant financial relationships with ineligible companies., 2024.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Irisflorentin improves functional recovery after spinal cord injury by protecting the blood–spinal cord barrier and promoting axonal growth;Experimental Neurology;2024-09

2. The interplay of p38 MAPK signaling and mitochondrial metabolism, a dynamic target in cancer and pathological contexts;Biochemical Pharmacology;2024-07